283 related articles for article (PubMed ID: 27911829)
1. Supramolecular PEGylation of biopharmaceuticals.
Webber MJ; Appel EA; Vinciguerra B; Cortinas AB; Thapa LS; Jhunjhunwala S; Isaacs L; Langer R; Anderson DG
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14189-14194. PubMed ID: 27911829
[TBL] [Abstract][Full Text] [Related]
2. Improved Physical Stability of an Antibody-Drug Conjugate Using Host-Guest Chemistry.
Sonzini S; Greco ML; Cailleau T; Adams L; Masterson L; Vijayakrishnan B; Barry C; Howard P; Ravn P; van der Walle CF
Bioconjug Chem; 2020 Jan; 31(1):123-129. PubMed ID: 31794200
[TBL] [Abstract][Full Text] [Related]
3. PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs.
Turecek PL; Bossard MJ; Schoetens F; Ivens IA
J Pharm Sci; 2016 Feb; 105(2):460-475. PubMed ID: 26869412
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular Protein Immobilization on Lipid Bilayers.
Bosmans RP; Hendriksen WE; Verheijden M; Eelkema R; Jonkheijm P; van Esch JH; Brunsveld L
Chemistry; 2015 Dec; 21(50):18466-73. PubMed ID: 26527541
[TBL] [Abstract][Full Text] [Related]
5. Cucurbit[7]uril: an emerging candidate for pharmaceutical excipients.
Kuok KI; Li S; Wyman IW; Wang R
Ann N Y Acad Sci; 2017 Jun; 1398(1):108-119. PubMed ID: 28692768
[TBL] [Abstract][Full Text] [Related]
6. Self-Healable Supramolecular Hydrogel Formed by Nor-Seco-Cucurbit[10]uril as a Supramolecular Crosslinker.
Park KM; Roh JH; Sung G; Murray J; Kim K
Chem Asian J; 2017 Jul; 12(13):1461-1464. PubMed ID: 28337859
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Supramolecular Hydrogels Spanning an Unprecedented Range of Host-Guest Affinity.
Zou L; Braegelman AS; Webber MJ
ACS Appl Mater Interfaces; 2019 Feb; 11(6):5695-5700. PubMed ID: 30707553
[TBL] [Abstract][Full Text] [Related]
8. Cucurbit[8]uril templated supramolecular ring structure formation and protein assembly modulation.
Ramaekers M; Wijnands SP; van Dongen JL; Brunsveld L; Dankers PY
Chem Commun (Camb); 2015 Feb; 51(15):3147-50. PubMed ID: 25604466
[TBL] [Abstract][Full Text] [Related]
9. Supramolecular polymeric chemotherapy based on cucurbit[7]uril-PEG copolymer.
Chen H; Chen Y; Wu H; Xu JF; Sun Z; Zhang X
Biomaterials; 2018 Sep; 178():697-705. PubMed ID: 29545011
[TBL] [Abstract][Full Text] [Related]
10. Incorporating Bacteria as a Living Component in Supramolecular Self-Assembled Monolayers through Dynamic Nanoscale Interactions.
Sankaran S; Kiren MC; Jonkheijm P
ACS Nano; 2015; 9(4):3579-86. PubMed ID: 25738514
[TBL] [Abstract][Full Text] [Related]
11. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
[TBL] [Abstract][Full Text] [Related]
12. Affinity-Directed Dynamics of Host-Guest Motifs for Pharmacokinetic Modulation
Maikawa CL; d'Aquino AI; Vuong ET; Su B; Zou L; Chen PC; Nguyen LT; Autzen AAA; Mann JL; Webber MJ; Appel EA
Biomacromolecules; 2021 Aug; 22(8):3565-3573. PubMed ID: 34314146
[TBL] [Abstract][Full Text] [Related]
13. Supramolecular approaches for insulin stabilization without prolonged duration of action.
Meudom R; Zhang Y; VandenBerg MA; Zou L; Zhang YW; Webber MJ; Chou DH
Acta Pharm Sin B; 2023 May; 13(5):2281-2290. PubMed ID: 37250160
[TBL] [Abstract][Full Text] [Related]
14. Vesicle formed by amphiphilc cucurbit[6]uril: versatile, noncovalent modification of the vesicle surface, and multivalent binding of sugar-decorated vesicles to lectin.
Lee HK; Park KM; Jeon YJ; Kim D; Oh DH; Kim HS; Park CK; Kim K
J Am Chem Soc; 2005 Apr; 127(14):5006-7. PubMed ID: 15810820
[TBL] [Abstract][Full Text] [Related]
15. Noncovalent PEGylation, An Innovative Subchapter in the Field of Protein Modification.
Reichert C; Borchard G
J Pharm Sci; 2016 Feb; 105(2):386-390. PubMed ID: 26523632
[TBL] [Abstract][Full Text] [Related]
16. Noncovalent PEGylation of protein and peptide therapeutics.
Andrianov AK
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1897. PubMed ID: 37138514
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular inhibition of amyloid fibrillation by cucurbit[7]uril.
Lee HH; Choi TS; Lee SJ; Lee JW; Park J; Ko YH; Kim WJ; Kim K; Kim HI
Angew Chem Int Ed Engl; 2014 Jul; 53(29):7461-5. PubMed ID: 24841324
[TBL] [Abstract][Full Text] [Related]
18. PEGylation of therapeutic proteins.
Jevsevar S; Kunstelj M; Porekar VG
Biotechnol J; 2010 Jan; 5(1):113-28. PubMed ID: 20069580
[TBL] [Abstract][Full Text] [Related]
19. Supramolecular formulation of nitidine chloride can alleviate its hepatotoxicity and improve its anticancer activity.
Li W; Yin H; Bardelang D; Xiao J; Zheng Y; Wang R
Food Chem Toxicol; 2017 Nov; 109(Pt 2):923-929. PubMed ID: 28223120
[TBL] [Abstract][Full Text] [Related]
20. N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH.
Hu J; Sebald W
Int J Pharm; 2011 Jul; 413(1-2):140-6. PubMed ID: 21539904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
